Mobia Medical (MOBI) Stock Price, News & Analysis

Company Overview

Key Stats

• Today's Range: $13.19 to $14.65
• 50-Day Range: N/A
• 52-Week Range: $10.19 to $15.29
• Volume: 135,395 shs
• Average Volume: 188,976 shs
• Market Capitalization: $486.43 million
• P/E Ratio: 66.00
• Dividend Yield: N/A
• Price Target: $20.25
• Consensus Rating: Moderate Buy

Mobia Medical Stock Analysis - MarketRank™

Mobia Medical scored higher than 79% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Mobia Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on no strong buy ratings, 5 buy ratings, 1 hold rating, and no sell ratings.

Upside Potential

Mobia Medical has a consensus price target of $20.25, representing about 38.4% upside from its current price of $14.63.

Amount of Analyst Coverage

Mobia Medical has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Mobia Medical is 66.00, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 45.96.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.49% of the float of Mobia Medical has been sold short.

Short Interest Ratio / Days to Cover

Mobia Medical has a short interest ratio ("days to cover") of 3.34, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Mobia Medical has recently increased by 140.33%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Mobia Medical does not currently pay a dividend.

Dividend Growth

Mobia Medical does not have a long track record of dividend growth.

News and Social Media

• Score: 2.1 / 5
• News Sentiment: 0.30

News Sentiment

Mobia Medical has a news sentiment score of 0.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Mobia Medical this week, compared to 3 articles on an average week.

Search Interest

5 people have searched for MOBI on MarketBeat in the last 30 days. This is an increase of 400% compared to the previous 30 days.

Company Ownership

• Score: 3.6 / 5
• Insider Trading: Acquiring Shares

Cluster Insider Buying

7 insiders have purchased shares of Mobia Medical in the last three months. Multiple insiders buying is a strong bullish signal.

Net Insider Buying

Over the last three months, insiders have purchased a net $19,088,930.00 in company stock, which represents 3.9243% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, Mobia Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $19,088,930.00 in company stock and sold $0.00 in company stock.

Percentage Held by Institutions

3.75% of the stock of Mobia Medical is held by institutions.

Company Calendar

• Last Earnings: 6/04/2026
• Today: 6/28/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:MOBI
• CIK: 1489993
• Web: N/A
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Mobia Medical: $20.25
• High Price Target: $31.00
• Low Price Target: $15.00
• Potential Upside/Downside: +38.4%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.83
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 66.00
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $38.45 million
• Price / Sales: 12.65
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 33,249,000
• Free Float: N/A
• Market Cap: $486.43 million
• Optionable: N/A
• Beta: 2.84